Terms: = Skin cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
1166 results:
1. Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer.
Yang Z; Wang Y; Huang S; Geng Y; Yang Z; Yang Z
PLoS One; 2024; 19(5):e0303650. PubMed ID: 38753638
[TBL] [Abstract] [Full Text] [Related]
2. Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.
Lin J; Zhu L; Chen Y; Li Q; Ke Z; Zhang H; Huang Y; Lu J; Chen Y
Acta Derm Venereol; 2024 May; 104():adv22146. PubMed ID: 38738772
[TBL] [Abstract] [Full Text] [Related]
3. miRSNP rs188493331: A key player in genetic control of microRNA-induced pathway activation in hypertrophic scars and keloids.
Chen M; Pan Y; Chen Z; Qi F; Gu J; Qiu Y; He A; Liu J
Skin Res Technol; 2024 May; 30(5):e13686. PubMed ID: 38682767
[TBL] [Abstract] [Full Text] [Related]
4. Curcumin Alone and Combined With pi3k Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
5. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
[TBL] [Abstract] [Full Text] [Related]
6. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
7. Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.
Li W; Zheng C; Xu X; Xia Y; Zhang K; Huang A; Zhang X; Zheng Y; Chen G; Zhang S
Cell Mol Biol Lett; 2024 Apr; 29(1):50. PubMed ID: 38594618
[TBL] [Abstract] [Full Text] [Related]
8. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via pi3k-AKT signaling pathway-mediated Keratin 14 degradation.
Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X
Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352
[TBL] [Abstract] [Full Text] [Related]
9. Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.
Mahmood N; Arakelian A; Szyf M; Rabbani SA
Exp Mol Med; 2024 Apr; 56(4):959-974. PubMed ID: 38556549
[TBL] [Abstract] [Full Text] [Related]
10. [Yes-associated protein (YAP) promotes invasion and migration of cutaneous squamous cell carcinoma cells by activating the pi3k/AKT pathway].
Li Z; Yang F; Jin X; Wang X; Chen T; Quan C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):244-251. PubMed ID: 38512035
[TBL] [Abstract] [Full Text] [Related]
11. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
12. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract] [Full Text] [Related]
13. Exosomes Derived from Mouse Breast Carcinoma Cells Facilitate Diabetic Wound Healing.
Zhang C; Xiao W; Wang H; Li L; Yang Y; Hao Y; Xu Z; Chen H; Nan W
Tissue Eng Regen Med; 2024 Jun; 21(4):571-586. PubMed ID: 38472732
[TBL] [Abstract] [Full Text] [Related]
14. Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion.
Lenskaya V; Yang RK; Cho WC
J Cutan Pathol; 2024 Jun; 51(6):419-423. PubMed ID: 38468567
[TBL] [Abstract] [Full Text] [Related]
15. Novel MED15::ATF1 fusion in a pediatric melanoma with spitzoid features and aggressive presentation.
Furtado LV; Cardenas M; Santiago T; Ruiz RE; Shi Z; Pappo A; Kacar M
Genes Chromosomes Cancer; 2024 Mar; 63(3):e23230. PubMed ID: 38459940
[TBL] [Abstract] [Full Text] [Related]
16. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
17. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract] [Full Text] [Related]
18. Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120's Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines.
Gao Y; Packeiser EM; Wendt S; Sekora A; Cavalleri JV; Pratscher B; Alammar M; Hühns M; Brenig B; Junghanss C; Nolte I; Murua Escobar H
Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397192
[TBL] [Abstract] [Full Text] [Related]
19. The Role of the PTEN Tumor Suppressor Gene and Its Anti-Angiogenic Activity in Melanoma and Other cancers.
Maphutha J; Twilley D; Lall N
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338464
[TBL] [Abstract] [Full Text] [Related]
20. Simultaneous inhibition of pi3k and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.
Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin HM; Fernandez-Valle C
Oncogene; 2024 Mar; 43(13):921-930. PubMed ID: 38336988
[TBL] [Abstract] [Full Text] [Related]
[Next]
